Abstract
Blocking the prostate cancer cells from interacting with the bone tissue, with the hope of slowing or preventing the development of bone metastases and thereby improving the outcomes, is the aim of treatment options for men with prostate cancer. Multidisciplinary care includes management with pain medications, external radiotherapy, radiopharmaceuticals, surgical treatment, chemotherapy, and bisphosphonates.